Hi Ed - yeah, this one definitely sat at the all you can eat buffet for a few weeks.
Market won't be able to ignore the biology forever. I'm sticking to $2.5-$3B. Its no accident the corporate decks break out previous IL-2 transactions and bi-specific transactions costs into that range.
Nothing says to me that Merck isn't interested. I'm sure they want to see the data just like everyone else. We will all find out in about 6-8 weeks.
David: When do you sleep? This is your longest article.
But nothing seems to move the needle.
Fahar Merchant said recently that MDNA 11 has “mega block buster potential “.
What is Medicenna worth?
Verona went for $8 billion for a COPD treatment.
Merus went for $8 billion for a head and neck treatment.
Certainly, that should indicate that MDNA 11 is worth more than $3 billion you indicated earlier.
Obviously, Merck is not interested.
When will it break??
Ed
Hi Ed - yeah, this one definitely sat at the all you can eat buffet for a few weeks.
Market won't be able to ignore the biology forever. I'm sticking to $2.5-$3B. Its no accident the corporate decks break out previous IL-2 transactions and bi-specific transactions costs into that range.
Nothing says to me that Merck isn't interested. I'm sure they want to see the data just like everyone else. We will all find out in about 6-8 weeks.